EDGAR Filing Documents for 0001654954-19-003927

Form 424B5 - Prospectus [Rule 424(b)(5)]:

SEC Accession No. 0001654954-19-003927

Filing Date

2019-04-02

Accepted

2019-04-02 08:56:59

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	424B5	azrx424b5_apr2019.htm	424B5	444738
2	IMAGE	ac_logo.jpg	GRAPHIC	9744
3	IMAGE	azurrx_logo000.jpg	GRAPHIC	5760
	Complete submission text file	0001654954-19-003927.txt		467425

Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226

Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855

AzurRx BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 424B5 | Act: 33 | File No.: 333-226065 | Film No.: 19722903
SIC: 2834 Pharmaceutical Preparations